Skip to main content
Clinical Trials/NCT02915549
NCT02915549
Completed
Not Applicable

Early Progressive Feeding in Human-Milk Fed Extremely Preterm Infants: A Randomized Trial

University of Alabama at Birmingham1 site in 1 country60 target enrollmentSeptember 2016

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Premature; Infant, Light-for-dates
Sponsor
University of Alabama at Birmingham
Enrollment
60
Locations
1
Primary Endpoint
Number of days alive and receiving full enteral feeding
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

To test the hypothesis that progressive feeding without minimal enteral feeding (MEF) compared to progressive feeding preceded by a 4-day course of MEF will result in an increased number of days alive on full enteral feeding in the first 28 days after birth in extremely preterm infants receiving human milk.

Detailed Description

Qualifying participants will be randomly assigned to one of two study groups: 1) Early progressive feeding without MEF or 2) Progressive feedings preceded by 4 days of MEF. Regardless of study group assignment, donor human milk will be offered if not enough of the mother's expressed breastmilk during the intervention phase of the trial. Intervention group: Progressive feeding of 20-24 ml/kg/d on day 1 of feeding, followed by daily increments of 24-25 ml/kg/d as tolerated until full enteral feeding achieved. Control group: MEF with feeding volumes of 20-24 ml/kg/d for 4 days followed by progressive feeding (daily increments of 24-25 ml/kg/d) as tolerated until full enteral feeding achieved. Both groups will receive fast progressive feeding (\>/= 24 ml/kg/day) If parent agrees, stool "dirty" diapers will be collected 5 times (at birth, 1, 2, 3 and 4 weeks of life).

Registry
clinicaltrials.gov
Start Date
September 2016
End Date
November 2022
Last Updated
3 years ago
Study Type
Interventional
Study Design
Parallel
Sex
All

Investigators

Responsible Party
Principal Investigator
Principal Investigator

Ariel A. Salas

Principal Investigator

University of Alabama at Birmingham

Eligibility Criteria

Inclusion Criteria

  • admission to the NICU within 48 hours with gestational age between 22.0 and 28.6 weeks

Exclusion Criteria

  • small for gestational age (\<10th percentile birthweight), major congenital or chromosomal anomalies, and infants with terminal illness in which decision to withhold or limit support have been made

Outcomes

Primary Outcomes

Number of days alive and receiving full enteral feeding

Time Frame: birth to 28 days

number of days alive on full enteral feeding in the first 28 days after birth

Secondary Outcomes

  • Changes in intestinal microbiome(birth to 28 days)
  • Number of participants with diagnosis of necrotizing enterocolitis(birth to 120 days or discharge, whichever occurs first)
  • Number of participants with diagnosis of intestinal perforation(birth to 14 days)
  • Death(birth to 120 days)
  • Number of days alive and receiving full enteral feeding according to time of exposure to human milk and formula feeding the first 28 days(birth to 28 days)
  • Time to establish full enteral feeding(birth to 28 days)
  • Number of episodes of feeding intolerance(birth to 28 days)
  • Number of episodes of feeding intolerance resulting in an interruption or cessation of progressive enteral feeding for a period < 12 hours(birth to 28 days)
  • Number of days receiving parenteral nutrition(birth to 28 days)
  • Number of days requiring central line access(birth to 28 days)
  • Number of episodes of culture proven sepsis(birth to 120 days or discharge, whichever occurs first)
  • Growth/length at time of discharge(birth to 120 days or discharge, whichever occurs first)
  • Duration of hospital stay in days(birth to 120 days or discharge, whichever occurs first)

Study Sites (1)

Loading locations...

Similar Trials